Mustang Bio
MBIO | NASDAQ
$0.48
-$0.03 (-5.31%)
At close: Sep 29, 2026, 4:00 PM ET
-5.31%
(1D)Rating
Key Statistics
Market Data
Market Cap $3.63M
1D Range
0.47 0.51
52W Range
0.47 1.85
Valuation (TTM)
PE -1.07
PB 0.48
EV/EBITDA 3.80
Valuation (NTM)
Forward PE N/A
Forward PEG -0.00
Price Target N/A
Cash Flow
FCF Yield -124.1%
SBC Adj. FCF Yield -126.0%
SBC Impact -1.5%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y 88.0% |
58.0%
FCF 3Y | 5Y 88.8% |
53.2%
Returns
ROA -19.4%
ROE -34.2%
ROIC -45.8%
Financial Health
Net Cash
$15.15M
Current Ratio 1.97
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases in the United States. The company...
Sector Healthcare
Industry Biotechnology
Employees 4
IPO Date Aug 22, 2017
Website www.mustangbio.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove MBIO